EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Splenic artery embolization for treatment of portal hypertension due to essential thrombocythemia

Jiacheng Liu, Xiaoming Liu, Bin Xiong

Portal Hypertension & Cirrhosis · 2022

DOI: 10.1002/poh2.25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Portal Hypertension & Cirrhosis, 2022. Verfasst von Jiacheng Liu und 2 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Philadelphia‐negative myeloproliferative neoplasms (MPNs) are significantly associated with the development of splanchnic vein thrombosis, which leads to portal hypertension. Here, we report two rare cases of portal hypertension caused by essential thrombocythemia (a type of MPN). Splenic artery embolization was performed to prevent variceal rebleeding, and during follow‐up, no rebleeding occurred in these two cases.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, J., Liu, X., & Xiong, B. (2022). Splenic artery embolization for treatment of portal hypertension due to essential thrombocythemia. Portal Hypertension & Cirrhosis. https://doi.org/10.1002/poh2.25

Vancouver

Liu J, Liu X, Xiong B. Splenic artery embolization for treatment of portal hypertension due to essential thrombocythemia. Portal Hypertension & Cirrhosis. 2022. doi:10.1002/poh2.25

BibTeX
@article{Liu2022,
  author = {Liu, Jiacheng and Liu, Xiaoming and Xiong, Bin},
  title = {Splenic artery embolization for treatment of portal hypertension due to essential thrombocythemia},
  journal = {Portal Hypertension & Cirrhosis},
  year = {2022},
  doi = {10.1002/poh2.25}
}
Kostenlos starten →